Prot #UWSC10294/NU UWF17D02: A Multicenter, Randomized, Double‐Blinded, Placebo‐Controlled, Phase 3 Trial of Adjuvant Avelumab (Anti‐PDL‐1 Antibody) in Merkel Cell Carcinoma Patients with Clinically Detected Lymph Node Metastases

Project: Research project

StatusActive
Effective start/end date4/1/185/31/22

Funding

  • University of Washington (Prot #UWSC10294/NU UWF17D02)
  • EMD Serono Research & Development Institute, Inc. (Prot #UWSC10294/NU UWF17D02)